BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $233,000 | -17.4% | 3,624 | -0.3% | 0.01% | -12.5% |
| Q1 2022 | $282,000 | -16.6% | 3,636 | -7.6% | 0.01% | -11.1% |
| Q4 2021 | $338,000 | -12.0% | 3,936 | -17.6% | 0.01% | -18.2% |
| Q3 2021 | $384,000 | -15.6% | 4,777 | -15.4% | 0.01% | -15.4% |
| Q2 2021 | $455,000 | -13.7% | 5,647 | -9.6% | 0.01% | -18.8% |
| Q1 2021 | $527,000 | -3.8% | 6,249 | -8.5% | 0.02% | -5.9% |
| Q4 2020 | $548,000 | -6.2% | 6,829 | -5.9% | 0.02% | -19.0% |
| Q3 2020 | $584,000 | -6.1% | 7,259 | +0.4% | 0.02% | -8.7% |
| Q2 2020 | $622,000 | 0.0% | 7,229 | -5.7% | 0.02% | -11.5% |
| Q1 2020 | $622,000 | -1.7% | 7,666 | +1.3% | 0.03% | +23.8% |
| Q4 2019 | $633,000 | +0.2% | 7,571 | +4.8% | 0.02% | -4.5% |
| Q3 2019 | $632,000 | +5.5% | 7,221 | -1.2% | 0.02% | +10.0% |
| Q2 2019 | $599,000 | -38.6% | 7,310 | -39.1% | 0.02% | -33.3% |
| Q1 2019 | $975,000 | +25.0% | 11,996 | +1.3% | 0.03% | +11.1% |
| Q4 2018 | $780,000 | -22.2% | 11,846 | -8.9% | 0.03% | -10.0% |
| Q3 2018 | $1,003,000 | +1.0% | 13,006 | -3.3% | 0.03% | 0.0% |
| Q2 2018 | $993,000 | +8.8% | 13,451 | -4.2% | 0.03% | +3.4% |
| Q1 2018 | $913,000 | -1.8% | 14,041 | -2.4% | 0.03% | -6.5% |
| Q4 2017 | $930,000 | +4.3% | 14,391 | +1.2% | 0.03% | +3.3% |
| Q3 2017 | $892,000 | +3.7% | 14,221 | +0.1% | 0.03% | -3.2% |
| Q2 2017 | $860,000 | +15.9% | 14,201 | -0.7% | 0.03% | +14.8% |
| Q1 2017 | $742,000 | +15.9% | 14,301 | -1.0% | 0.03% | +3.8% |
| Q4 2016 | $640,000 | -17.2% | 14,441 | -11.1% | 0.03% | -16.1% |
| Q3 2016 | $773,000 | +4.9% | 16,249 | -0.2% | 0.03% | +3.3% |
| Q2 2016 | $737,000 | +10.3% | 16,289 | +0.2% | 0.03% | +7.1% |
| Q1 2016 | $668,000 | +10.0% | 16,249 | +2.1% | 0.03% | +7.7% |
| Q4 2015 | $607,000 | +10.2% | 15,919 | -5.0% | 0.03% | +8.3% |
| Q3 2015 | $551,000 | -78.5% | 16,759 | -54.3% | 0.02% | -77.1% |
| Q2 2015 | $2,564,000 | -90.0% | 36,671 | -90.2% | 0.10% | -90.4% |
| Q1 2015 | $25,651,000 | +25.0% | 374,467 | +33.7% | 1.09% | +8.8% |
| Q4 2014 | $20,520,000 | +10.2% | 279,983 | +7.9% | 1.00% | +2.7% |
| Q3 2014 | $18,623,000 | +4.9% | 259,481 | +5.7% | 0.98% | +3.4% |
| Q2 2014 | $17,754,000 | -0.3% | 245,555 | +1.5% | 0.94% | -9.8% |
| Q1 2014 | $17,808,000 | +8.6% | 242,018 | +2.6% | 1.05% | +3.0% |
| Q4 2013 | $16,402,000 | +43.3% | 235,837 | +35.4% | 1.02% | +14.9% |
| Q3 2013 | $11,443,000 | -2.3% | 174,202 | +3.0% | 0.88% | -8.7% |
| Q2 2013 | $11,718,000 | – | 169,164 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |